bf/NASDAQ:DICE_icon.jpeg

NASDAQ:DICE

DICE Therapeutics, Inc.

  • Stock

USD

Last Close

47.52

08/08 20:00

Market Cap

2.27B

Beta: -

Volume Today

4.33M

Avg: 534.33K

PE Ratio

−23.17

PFCF: −26.04

OverviewFinancialsAPI

    Description

    DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lead therapeutic candidate is DC-806...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -1-0.50.511.522.52020-09-302021-09-162022-05-122023-03-152023-11-08

    Revenue (Estimate*)

    200K400K600K800K1M1.20M2020-09-302021-09-162022-05-122023-03-152023-11-08

    *Estimate based on analyst consensus